tirzepatide approval obesity TrimRX Is Mounjaro Gliding Toward an

384(26): 24912492." Accessed on April 3, 2024, at PubMed Central (PMC) - "J Nephrol Ther

The dual agonist action on GLP-1 and GIP appears to increase appetite suppression and metabolic benefit compared to GLP-1-only agents

The dual action of Tirzepatide effectively reduces caloric intake while improving glucose metabolism, which explains why the SURMOUNT-1 trial data showed up to a 22.5% mean weight reduction at the 72-week mark

Weight loss usually becomes visible within the first couple of months and continues steadily over time

I lost 18 pounds in 4 months and felt more fit and energetic, he said

Dove trovare Mounjaro